BI-2536 10mg | ≥96%
CSNpharm
BI-2536 is a potent Plk1 inhibitor with IC50 of 0.83 nM, BI2536 shows 4- and 11-fold greater selectivity against Plk2 and Plk3 and also is a BRD4 inhibitor (IC50= 25 nM).
More Information Supplier Page
BI-2536 is a potent Plk1 inhibitor with IC50 of 0.83 nM, BI2536 shows 4- and 11-fold greater selectivity against Plk2 and Plk3 and also is a BRD4 inhibitor (IC50= 25 nM).
More Information Supplier Page
BI-2536 is a potent Plk1 inhibitor with IC50 of 0.83 nM, BI2536 shows 4- and 11-fold greater selectivity against Plk2 and Plk3 and also is a BRD4 inhibitor (IC50= 25 nM).
More Information Supplier Page
Butamben is a long-duration local anesthetic used for the treatment of chronic pain.
More Information Supplier Page
Butamben is a long-duration local anesthetic used for the treatment of chronic pain.
More Information Supplier Page
TRIS base is an established basimetric standard and buffer used in biochemistry and molecular biology.
More Information Supplier Page
Pyrazinamide is a synthetic pyrazine analogue of nicotinamide as an anti-tuberculous agent.
More Information Supplier Page
Pyrazinamide is a synthetic pyrazine analogue of nicotinamide as an anti-tuberculous agent.
More Information Supplier Page
Levetiracetam is an anticonvulsant with antihyperalgesic efficacy in inflammatory pain. It binds the synaptic vesicle protein SV2A (pIC50 = 5.7), presumably altering vesicle exocytosis.
More Information Supplier Page
Levetiracetam is an anticonvulsant with antihyperalgesic efficacy in inflammatory pain. It binds the synaptic vesicle protein SV2A (pIC50 = 5.7), presumably altering vesicle exocytosis.
More Information Supplier Page
6-Aminocaproic Acid inhibits the plasmin activating enzymes streptokinase, fibrinokinase and urokinase, it is an antifibrinolytic agent.
More Information Supplier Page